Vitrolife´s CEO has purchased shares
On October 28, 2022, Thomas Axelsson, CEO of Vitrolife, acquired 12,000 shares valued at 2,124,000 MSEK, increasing his total holdings to 25,000 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On October 28, 2022, Thomas Axelsson, CEO of Vitrolife, acquired 12,000 shares valued at 2,124,000 MSEK, increasing his total holdings to 25,000 shares. This transaction adheres to regulatory requirements and will be reported to the Swedish Financial Supervisory Authority. The information is disclosed under the EU Market Abuse Regulation and the Securities Markets Act, ensuring compliance and transparency regarding executive stock purchases.
Positive
- CEO Thomas Axelsson's personal investment of 2,124,000 MSEK indicates confidence in Vitrolife's future performance.
- Increase in total shares held by the CEO to 25,000 demonstrates strong commitment.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GOTHENBURG, Sweden, Oct. 28, 2022 /PRNewswire/ -- Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 MSEK. The total holdings of shares amount to 25,000.
The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
Gothenburg, October 28, 2022
VITROLIFE AB (publ)
Thomas Axelsson, CEO
CONTACT:
Contact persons:
Thomas Axelsson,
CEO,
phone: +46 31 721 80 01
Patrik Tolf,
CFO,
phone: +46 31 766 90 21
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.45 am CET on October 28, 2022.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
The following files are available for download:
Vitrolife´s CEO has purchased shares |
View original content:https://www.prnewswire.com/news-releases/vitrolifes-ceo-has-purchased-shares-301662183.html
SOURCE Vitrolife AB (publ)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.